Literature DB >> 2536138

Resistance to antiviral drugs: the end of innocence.

M S Hirsch, R T Schooley.   

Abstract

Mesh:

Substances:

Year:  1989        PMID: 2536138     DOI: 10.1056/NEJM198902023200510

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  14 in total

Review 1.  Prophylaxis for genital herpes. Should it be used routinely?

Authors:  A Mindel
Journal:  Drugs       Date:  1991-03       Impact factor: 9.546

2.  Oral ganciclovir usage for cytomegalovirus prophylaxis in organ transplant recipients: is emergence of resistance imminent?

Authors:  N Singh; V L Yu
Journal:  Dig Dis Sci       Date:  1998-06       Impact factor: 3.199

Review 3.  Infections in solid-organ transplant recipients.

Authors:  R Patel; C V Paya
Journal:  Clin Microbiol Rev       Date:  1997-01       Impact factor: 26.132

4.  A net +1 frameshift permits synthesis of thymidine kinase from a drug-resistant herpes simplex virus mutant.

Authors:  C B Hwang; B Horsburgh; E Pelosi; S Roberts; P Digard; D M Coen
Journal:  Proc Natl Acad Sci U S A       Date:  1994-06-07       Impact factor: 11.205

5.  The extreme C terminus of herpes simplex virus DNA polymerase is crucial for functional interaction with processivity factor UL42 and for viral replication.

Authors:  P Digard; W R Bebrin; K Weisshart; D M Coen
Journal:  J Virol       Date:  1993-01       Impact factor: 5.103

6.  Specific inhibition of herpes simplex virus DNA polymerase by helical peptides corresponding to the subunit interface.

Authors:  P Digard; K P Williams; P Hensley; I S Brooks; C E Dahl; D M Coen
Journal:  Proc Natl Acad Sci U S A       Date:  1995-02-28       Impact factor: 11.205

Review 7.  "The end of innocence" revisited: resistance of herpesviruses to antiviral drugs.

Authors:  A K Field; K K Biron
Journal:  Clin Microbiol Rev       Date:  1994-01       Impact factor: 26.132

Review 8.  Cutaneous manifestations of opportunistic infections in patients infected with human immunodeficiency virus.

Authors:  J W Tappero; B A Perkins; J D Wenger; T G Berger
Journal:  Clin Microbiol Rev       Date:  1995-07       Impact factor: 26.132

Review 9.  Pathogenesis of human immunodeficiency virus infection.

Authors:  J A Levy
Journal:  Microbiol Rev       Date:  1993-03

10.  Passive immunization against cytomegalovirus in allograft recipients. The Rotterdam Heart Transplant Program experience.

Authors:  A H Balk; W Weimar; P H Rothbarth; K Meeter; H J Metselaar; B Mochtar; M L Simoons
Journal:  Infection       Date:  1993 Jul-Aug       Impact factor: 3.553

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.